Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Genentech’s Subcutaneous Formulation of Rituximab Report
Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Genentech’s Subcutaneous Formulation of Rituximab Report